Vier J, Hacker G, Kirschnek S
Cell Death Dis. 2024; 15(9):677.
PMID: 39285161
PMC: 11405755.
DOI: 10.1038/s41419-024-07064-z.
Vitale I, Pietrocola F, Guilbaud E, Aaronson S, Abrams J, Adam D
Cell Death Differ. 2023; 30(5):1097-1154.
PMID: 37100955
PMC: 10130819.
DOI: 10.1038/s41418-023-01153-w.
Gangoda L, Schenk R, Best S, Nedeva C, Louis C, DSilva D
Cell Death Differ. 2021; 29(1):96-104.
PMID: 34304242
PMC: 8738744.
DOI: 10.1038/s41418-021-00839-3.
Davydova E, Shimazu T, Schuhmacher M, Jakobsson M, Willemen H, Liu T
Nat Commun. 2021; 12(1):891.
PMID: 33563959
PMC: 7873184.
DOI: 10.1038/s41467-020-20670-7.
Josefsson E, Vainchenker W, James C
Int J Mol Sci. 2020; 21(20).
PMID: 33066573
PMC: 7589436.
DOI: 10.3390/ijms21207591.
The essentials of developmental apoptosis.
Voss A, Strasser A
F1000Res. 2020; 9.
PMID: 32148779
PMC: 7047912.
DOI: 10.12688/f1000research.21571.1.
GM-CSF Quantity Has a Selective Effect on Granulocytic vs. Monocytic Myeloid Development and Function.
Sun L, Rautela J, Delconte R, Souza-Fonseca-Guimaraes F, Carrington E, Schenk R
Front Immunol. 2018; 9:1922.
PMID: 30210491
PMC: 6120981.
DOI: 10.3389/fimmu.2018.01922.
Anti-apoptotic A1 is not essential for lymphoma development in Eµ-Myc mice but helps sustain transplanted Eµ-Myc tumour cells.
Mensink M, Anstee N, Robati M, Schenk R, Herold M, Cory S
Cell Death Differ. 2018; 25(4):797-808.
PMID: 29339775
PMC: 5864240.
DOI: 10.1038/s41418-017-0045-8.
The life and death of immune cell types: the role of BCL-2 anti-apoptotic molecules.
Carrington E, Tarlinton D, Gray D, Huntington N, Zhan Y, Lew A
Immunol Cell Biol. 2017; 95(10):870-877.
PMID: 28875977
DOI: 10.1038/icb.2017.72.
Ly6C Monocytes and Their Macrophage Descendants Regulate Neutrophil Function and Clearance in Acetaminophen-Induced Liver Injury.
Graubardt N, Vugman M, Mouhadeb O, Caliari G, Pasmanik-Chor M, Reuveni D
Front Immunol. 2017; 8:626.
PMID: 28620383
PMC: 5451509.
DOI: 10.3389/fimmu.2017.00626.
The RNA-binding protein tristetraprolin schedules apoptosis of pathogen-engaged neutrophils during bacterial infection.
Ebner F, Sedlyarov V, Tasciyan S, Ivin M, Kratochvill F, Gratz N
J Clin Invest. 2017; 127(6):2051-2065.
PMID: 28504646
PMC: 5451238.
DOI: 10.1172/JCI80631.
Dying to protect: cell death and the control of T-cell homeostasis.
Li K, Shanmuganad S, Carroll K, Katz J, Jordan M, Hildeman D
Immunol Rev. 2017; 277(1):21-43.
PMID: 28462527
PMC: 5416827.
DOI: 10.1111/imr.12538.
The Bcl2a1 gene cluster finally knocked out: first clues to understanding the enigmatic role of the Bcl-2 protein A1.
Berberich I, Hildeman D
Cell Death Differ. 2017; 24(4):572-574.
PMID: 28338657
PMC: 5384030.
DOI: 10.1038/cdd.2017.25.
Characterisation of mice lacking all functional isoforms of the pro-survival BCL-2 family member A1 reveals minor defects in the haematopoietic compartment.
Schenk R, Tuzlak S, Carrington E, Zhan Y, Heinzel S, Teh C
Cell Death Differ. 2017; 24(3):534-545.
PMID: 28085150
PMC: 5344213.
DOI: 10.1038/cdd.2016.156.
Killing Two Cells with One Stone: Pharmacologic BCL-2 Family Targeting for Cancer Cell Death and Immune Modulation.
Ludwig L, Nassin M, Hadji A, LaBelle J
Front Pediatr. 2017; 4:135.
PMID: 28066751
PMC: 5174130.
DOI: 10.3389/fped.2016.00135.
BAX to basics: How the BCL2 gene family controls the death of retinal ganglion cells.
Maes M, Schlamp C, Nickells R
Prog Retin Eye Res. 2017; 57:1-25.
PMID: 28064040
PMC: 5350025.
DOI: 10.1016/j.preteyeres.2017.01.002.
The anti-apoptotic Bcl-2 family protein A1/Bfl-1 regulates neutrophil survival and homeostasis and is controlled via PI3K and JAK/STAT signaling.
Vier J, Groth M, Sochalska M, Kirschnek S
Cell Death Dis. 2016; 7:e2103.
PMID: 26890142
PMC: 5399193.
DOI: 10.1038/cddis.2016.23.
Targeting BCL2-Proteins for the Treatment of Solid Tumours.
Vogler M
Adv Med. 2015; 2014:943648.
PMID: 26556430
PMC: 4590949.
DOI: 10.1155/2014/943648.
Conditional knockdown of BCL2A1 reveals rate-limiting roles in BCR-dependent B-cell survival.
Sochalska M, Ottina E, Tuzlak S, Herzog S, Herold M, Villunger A
Cell Death Differ. 2015; 23(4):628-39.
PMID: 26450454
PMC: 4986635.
DOI: 10.1038/cdd.2015.130.
Lessons from gain- and loss-of-function models of pro-survival Bcl2 family proteins: implications for targeted therapy.
Sochalska M, Tuzlak S, Egle A, Villunger A
FEBS J. 2015; 282(5):834-849.
PMID: 25559680
PMC: 4562365.
DOI: 10.1111/febs.13188.